Rocket Pharmaceuticals Inc

We track 2 ClinicalTrials.gov studies led by Rocket Pharmaceuticals Inc. The portfolio skews toward Phase 1 (1 trials).

2 clinical trials sponsored by Rocket Pharmaceuticals Inc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 1
50%
N/A 1
50%

Trial Status Breakdown

Trials by Rocket Pharmaceuticals Inc

A Phase 1 Dose Escalation Trial Evaluating an Intravenously Administered Recombinant Adeno-associated Virus Serotype rh.74 (AAVrh.74) Vector Containing the Human BCL2-associated Athanogene 3 (BAG3) Gene Coding Sequence (RP-A701) in Subjects With Dilated Cardiomyopathy Arising From Pathogenic BAG3 Variants (BAG3-DCM)

NCT07137338 · RECRUITING · Phase 1

An Observational Study of Genetic Cardiomyopathy, Danon Disease

NCT06214507 · RECRUITING · N/A

Frequently Asked Questions

How many clinical trials does Rocket Pharmaceuticals Inc sponsor?

Rocket Pharmaceuticals Inc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 1, N/A.

What conditions does Rocket Pharmaceuticals Inc research?

Rocket Pharmaceuticals Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Rocket Pharmaceuticals Inc recruiting for clinical trials?

Yes, Rocket Pharmaceuticals Inc currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More